Article
20 Oct 2025
Watch Out Section 101, The USPTO Has A New Sheriff In Town
AUTHORS CONTENT
Article
14 Mar 2025
FDA Accepts BLA For Amneal's Denosumab Biosimilars
Article
11 Feb 2025
FDA Accepts BLA For Shanghai Henlius Biotech's HLX11, A Pertuzumab Biosimilar
Article
17 Oct 2024
Teva And MAbxience Add Additional Oncology Biosimilar Candidate, Expanding Strategic Partnership
Article
17 Jan 2024
Issue 43: PTAB Trial Tracker
Article
23 Aug 2023
GSK Sues Pfizer For Patent Infringement Over RSV Vaccine
Article
28 Feb 2023
Fresenius Kabi Launches STIMUFEND (pegfilgrastim-fpgk) In The United States
Article
19 Dec 2022
Fresenius Kabi Announces FDA Approval Of Adalimumab Biosimilar
Article
13 Oct 2022
Biogen Announces EMA Acceptance Of Tocilizumab Biosimilar Application
Article
20 May 2022
Teva Receives Approval For First Ophthalmology Biosimilar In Europe
Article
18 Apr 2022
International Biosimilar Approval And Launch Updates